chrisvoncsefalvay/vaers-outcomes huggingface dataset:
15 minutes after vaccination received, she says she had a sore throat but did not tell anyone at the vaccination site. Started feeling that left hand was burning. Then started getting nauseous 3.5 hrs later with upset stomach. Then had "burning" feeling in all her joints (migratory in pattern). Then headache. Then face numb on left side (never happened before, usually gets the numbness on the right side with her atypical migraines) - still numb 1 day later when she discussed with me. Could not sleep the night after getting the vaccine. - No new BEFAST symptoms (balance issues - usually has some imbalance issue, visual changes, facial asymmetry, arm/leg weakness, speech slurring or difficulty)   All joint pains resolved 1 day later. Arm is sore 1 day later with left hand pain. Still nauseous 1 day later. Nausea resolved within 1 week.
0810- C/O FAST HEART RATE, FLUSHING, FEELING, LAST 3-5 MIN. 0815 S/S  EXCEPT A HEADACHE IN TH BACK OF THE HEAD. PT STATED A HISTORY OF GETTING H/A. MONITORING V.S. WATER OFFERED REFUSED HAD BREAKFAST.  0810-02 SAT 99% 0812 HR 68 0815 BP 142/82-SAT 99% RR 20 HR 65 0824 99%  RR 20 HR 67 0825 BP- 112/78 RR 16 Patient felt well enough to leave
Patient came to get a flu vaccine. Upon consultation prior to vaccine she gets the vaccine every year with no adverse reaction. After giving the patient the flu vaccine about 5 minutes later the patient stated she was not feeling well so the pharmacist asked her to have a seat and gave her some water about 2 minutes later patient fainted in her chair. We called 911 immediately within a couple of minutes the paramedics came and took the patient to the hospital
Patient came in for first COVID-19 shot. Mom denied any reaction in the past to other vaccines. COVID-19 vaccine administered to his left arm. During 20 min of observation, patient started shaking and fell to the floor. MD came in right away and evaluated patient. Vitals taken. 127/56, 65 HR, 100%. Patient re-observed for another 20 minutes. He reported feeling dizzy again and stomachache. Patient transported to ER.
"PT RECEIVED THE PNEUMONIA VACCINE YESTERDAY IN HIS LEFT DELTOID, LAST EVENING IT BECAME PAINFUL, (SCALE OF 1-10: 10), SWOLLEN AND RED. THE PAIN TRAVELS DOWN HIS ARM, THE REDNESS AND SWELLING IS STARTING TO GO AWAY, HE DOESN'T SEE RED OR BLUE STREAKING IN THE ARM, THERE ISN'T A RASH. HE'S ABLE TO BEND AT THE ELBOW, HIS FINGERS FEEL "A LITTLE " TINGLY. HE DOESN'T HAVE FACIAL OR TONGUE SWELLING, NO  SHORTNESS OF BREATH, SWEATING, JAW OR CHEST PAIN, NO CHILLS. HIS VOICE ISN'T HOARSE, HE DOESN'T HAVE A HEADACHE, NO NECK STIFFNESS. HE'S NOT HAVING NAUSEA, VOMITING, OR DIARRHEA. HIS WIFE FELT THE ARM COMPARING IT TO THE OTHER, IT FEELS HOT. HE DOESN'T HAVE ANY ALLERGIES THAT HE KNOWS OF, "I'VE HAD ALL KINDS OF SHOTS AND NEVER HAD A REACTION." PT WILL REPORT TO URGENT CARE THIS AFTERNOON."
Chronic pain has worsened since the second dose. My ability to walk is deteriorating. My physical and mental health is declining. My left side affected by CRPS is spreading to right side. The extreme pain possibly caused by cytokines level.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a female patient who received SHINGRIX. On 15th May 2018, the patient received the 1st dose of SHINGRIX. On 20th May 2018, 5 days after receiving SHINGRIX, the patient experienced shingles. The patient was treated with antivirals for systemic use. On an unknown date, the outcome of the shingles was recovering/resolving. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The caller stated that the patient received 1st dose of SHINGRIX and went to her physician on 20th May 2018. The patient's physician diagnosed patient with shingles and prescribed anti-viral medication. The caller did not had additional details during the call.
Patient was schedule for 2nd dose COVID19 vaccine, one one to early. Patient was in room for 15 minutes after vaccine was administered no symptoms or signs of destressed.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 3:09 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 3:09 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 43.53.  Concomitant products were not provided.  On 14-Feb-2021, Excursion time was 09 AM, 10 AM, 11 AM, 2 PM and 3 PM, temperature was 32, 32,32, 35 and 35, total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Initial face flushing (first few hours) Mild headache (first 36 hours)  General tiredness - ongoing  Moderate Pain in left arm and left shoulder (11-36 hours) Noticeable muscle or nerve twitching in right leg when at rest - from about 11 hours and ongoing increasing in area.
The potential side effect was that I developed shingles on the left side of my head on the top. I seen my doctors and they just prescribed me some medications for it.
No adverse symptoms reported; One expired dose of RECOMBIVAX was administered; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug allergies/reactions were not provided. On 15-NOV-2019, the patient was vaccinated with one expired dose of hepatitis b vaccine (recombinant) (thimerosal free) (RECOMBIVAX HB) injection 10/1 microgram/milliliter (mcg/ml) lot # N006321, expiration date: 08-NOV-2019 (dose number, anatomical location and route of administration were not provided) for prophylaxis (expired product administered). No adverse symptoms reported. No product quality complaints (PQC) were involved.
Patient received vaccine at mass dispensing clinic (flu drive-by clinic) and staffed by the Public Health Department sometime during the hours of 8:30 AM-3:30 PM on 09/27/17. Patient notified clinic 2 days later that she had experienced muscle weakness to all extremities starting the evening of the date of administration (09/27/17) and was seen by her physician's office on 09/28/17. Clinic notes received from physician's office. Per clinic notes, neurological exam in office normal, but due to patient's complaints of weakness the prior evening, notes state for patient to list flu vaccine as an allergy. Per the clinic notes, symptoms were listed as Guillain Barre' type symptoms. Recommendations from physician's office were to increase fluids and ibuprofen and go to ER if symptoms worsen. When health department contacted clinic 2 days after vaccination, patient stated she was feeling better and was returning to work that day.
This spontaneous report was received from a physician referring to a currently 7 year old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 21-JUL-2010, the patient was vaccinated with a dose of M-M-R II lot number reported as: 10594, expiration date on 24-JUL-2011 (strength, dose number, route and anatomical location were not provided) for prophylaxis. On 24-FEB-2014, the patient was vaccinated with a dose of PROQUAD lot number reported as: J011326, expiration date on 13-MAR-2020 (strength, dose number, route and anatomical location were not provided) for prophylaxis. On an unknown date, the patient experienced swollen salivary glands and fever. It was reported that on 06-MAR-2017, the patient went to the physician office and was treated with clindamycin. At the time of the report, the outcome of salivary gland enlargement and pyrexia was reported as recovered on an unspecified date in 2017. The reporter did not assess the relatedness between enlargement and pyrexia and suspect therapies. This is one of several reports received from the same reporter. Lot number 10594 is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live. Lot number J011326 has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live. Additional information is not expected, since no consent to contact the reporter was provided. This is an amended report, as corrected. The reference type for the number US-009507513-1703USA006841 was changed from Company Number to Linked Report. Sender's Comments: US-009507513-1703USA008042: US-009507513-1703USA006841: US-009507513-1703USA006841: US-009507513-1704USA008485: US-009507513-1704USA008486.
pt recvd vax;red line appeared about 1/2" in diam & grew towards knee;mom reports there is a firm knot felt in area of shot;area slightly pink;
Left thigh swollen, pink, hot to touch, not tender. Advised use of cold pack,Benadryl if itchy or uncomfortable , return if pain or fever. DTaP only vax in left thigh.
Complaints of feeling flush, increased heart rate and jitter at around 8:52 following a COVID-19 injection at 8:45.
88y.o. female presenting with altered mental status. Upon presentation she was found to be COVID-positive which was likely source of her altered mental status. MRI brain demonstrated remote left parietal infarct with possible small acute infarcts in left occipital lobe. This was likely secondary to longstanding hypertension. Additionally, was found to have hypertensive urgency. She does have element of CKD with acutely elevated creatinine. Creatinine resolved to previous level with IV fluids. In terms of her blood pressure, metoprolol and clonidine were increased. Once her renal function resolved to baseline, losartan was resumed. Blood pressure was still elevated, and calcium channel blocker was added. This achieved acceptable control of her blood pressure. Following this, she was stable for discharge home. Family is able to provide care for her. She was discharged home accordingly to follow-up expediently with her primary care physician. Patient's daughter had already been in discussion with primary care to set up follow-up appointment.
1531 -patient checked in 1540- taken to room and consent signed (Flu vaccine) 1542 - vaccine administered 1545- was sitting in teen waiting for the observation period. mother asked me for water -  patient given Gatorade. As mom was walking back to waiting area- CMA and another CMA saw that the child was pale. They helped support her to the treatment room to lay down. child went limp and diaphoretic. Child assisted to the ground. Pulse was 49 at time of event. 1547- patient moved to table with head elevated. pulse up to 66 1550- child alert and oriented to room- was able to drink most of the Gatorade. remembers event 1615- patient well enough to leave office. patient walked from office on her own.
4/4/2021  7:00 pm vaccine site and arm pain 8:30 pm Chills. Temp 100. 4/5/2021  3:00 am Increased pain vaccine arm, chills, temperature 101.1, severe headache, muscle pain, joint pain, neck and back stiffness, fatigue, nausea, mild diarrhea. No ekes is. 8:00 am. Temperature 101.3. Headache. Entire body aches as though I have Influenza. Neck and shoulders stiffness. Severely fatigued. No appetite. Slept all day. Didn?t eat. 4/6/2021 Tired but pains lessened. Other symptoms mild.
Mom states the pt had a high fever starting on 7/17/00 of 103 degrees and a cough.
he tested positive for Covid-19; he tested positive for Covid-19; This is a spontaneous report from a contactable physician (Patient) from a Pfizer-sponsored program. A male patient of an unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on an unknown date in Jan2021, as a single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on an unknown date in Dec2020, as a single dose for COVID-19 immunization. Reporter stated that he received his first dose of the vaccine in Dec2020 and his second dose in Jan2021 but did not remember the dates. 24 hours after the second dose (in Jan2021), he tested positive for COVID-19 and he thought it was just a reaction to the vaccine. Another 36 hours later he received monoclonal antibodies. He asked if it is recommended that the vaccine be repeated given the timing of the monoclonal antibody therapy. It was also reported that patient received both dose of COVID vaccine 18 or 19 days apart. Right after 2nd dose of COVID vaccine, came down with COVID virus. Outcome of the event was unknown.  Information on about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the second vaccine dose and the event onset.
Woke up Wed morn. Right foot was numb. Hardly any feeling. Called doc. Thursday she said go to emergency room. Sounded like I had a blood clot. Went to ER. They said no clots. Sat had same symptoms in left foot up left leg and in my hands a week later went to ER. They done blood work and stool sample test. Still no better. A week later went to ER. Said I had GBS. They did a spinal tap. Then started IVIG infusion took it for five days.
COVID-19 positive post full vaccination. Asymptomatic. Found on routine employee screening.
Patient contacted clinic six days after receiving Flu vaccine and stated that she broke out in itchy hives all over her body one day after receiving the vaccine.  She stated that hives are still present and that she has been taking Benadryl, which helps with the itching.  She denies any difficulty breathing or swelling of the face, lips, or tongue since receiving the Flu shot on 12/7/22.  Instructed patient to follow up with her primary care provider today for evaluation.  Instructed to seek emergency medical care immediately if patient develops any swelling of the face, lips, tongue, and/or difficulty breathing. Follow up phone call to patient the afternoon of the report (12/13/22):  Patient states she went to see her primary care provider and was given a prescription for her hives (unsure of medication name).  Patient states she started taking the medication and it is helping with the hives and itching.  She denies any further signs/symptoms of reaction.
numbness of the lower left face, cheek and area around the mouth (peri-oral and mandibular numbness); numbness of the lower left face, cheek and area around the mouth (peri-oral and mandibular numbness); This is a spontaneous report from a contactable physician reporting for a patient.  A 37-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly  on 19Dec2020 (at the age of 37-years old) as a single dose for COVID-19 vaccination. The facility where the most recent COVID-19 vaccine was administered was a hospital. Prior to vaccination, the patient had not been diagnosed with COVID-19. The patient's medical history and concomitant medications were not reported.  It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Dec2020, the patient experienced numbness of the lower left face, cheek and area around the mouth (peri-oral and mandibular numbness). No treatment was received for the adverse events. The patient was recovering from the events.Since the vaccination, has the patient has not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Rash developed on my face within the first hour of receiving shot. Have taken an antihistamine to help reduce the itching--which is only annoying, not extreme. Seems to be lessening after 13 hours.
Case number PHEH2011US06128, is an initial spontaneous report received from a consumer on 04 Oct 2011: This report refers to a female adolescent. Medical history included hypersensitivity (numerous reactions) due to failure of immunoglobulin E (IgE). She was vaccinated with seasonal influenza virus vaccine (batch number and manufacturer unknown) two or three years ago. After vaccination, her arm swelled up and it looked as "big as an elephant leg", Body temperature increased to 105 degree Fahrenheit and this persisted for six days, and then it dropped to 101 degree Fahrenheit. Her whole arm, whole the way down to her finger was red. Her immunologist thought that this reaction was due to the preservative in the vaccine since she was eating preservative free diet.
Pt. c/o itching of eyes, abdomen, behind ears and sore throat.  Denied SOB or chest pain.  Hx of anaphylaxis to TDap and NSAIDs.  Pt stated felt similar to other reactions in past.  0917 BP 175/112 and 0927 170/105.  Pt. states forgot to take BP meds.  0921 Benedryl 50 mg IM given per Dr. orders.  Pt. observed for 20 min and reported all symptoms subsided.  Pt. released to home driven by spouse.
When I received the vaccine, the day after I felt sick with severe fatigue and body aches. I felt feverish but I didn't have a fever. I felt like I had a bad case of the flu. I was in bed for 3 or 4 days, and then I started feeling better. Then I got a UTI. I started taking nitrofurantoin for it for 5 days. About a week later on a Friday night I had severe stomach bloating and a sick feeling. The next day I went to the local urgent care clinic. The doctor examined me and said she think that I was having a stomach virus that was going around. She advised me to take some gas-x pills so I took simethicone. When I followed up with my PCP I had a low grade fever. She examined me and said everything was okay and thought it was a stomach virus as well. They said it would last about 10 days. It has been going on for 8 days so far, and I am still not back to normal as of right now. I also took some Tylenol as well. I've recovered from the UTI but not the stomach virus yet.
A non-serious, spontaneous report of sore throat, fever, body ache, runny nose and congestion was received from  a consumer, concerning a five year-old male patient, subsequent to FLUMIST.  Neither relevant medical history nor concomitant medications have been reported for this patient.  The patient received FLUMIST on Monday, 29-Sep-2008.  On Tuesday, 30-Sep-2008 the patient experienced a sore throat, fever, body aches, runny nose and congestion, which are ongoing.  The events were ongoing as of Monday, 06-Oct-2008.
Received vaccine was administered to the patient on 2/8/10 (H1N1).
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 11-MAY-2016, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster with complications. On or about 25-MAY-2016, the patient was treated by a physician for a persistent and severe vesicular rash accompanied by nerve pain which was diagnosed as severe herpes neuropathy. The patient has been prescribed KENALOG and tramadol for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
On day 2 evening the 5th I developed severe arm soreness. Could not lift or put pressure on it. That evening I developed fever that lasted a full day. On the 8th I have numbness and tingling on the same left arm.
I have had occasional brief chest pains, like a painful tightness around my heart that lasts a couple seconds at a time.  They have been random and infrequent enough I have not done anything about it (also, I am currently uninsured), but v-safe suggested I should submit a VAERS report of it anyway.  Obviously I cannot be entirely sure it is related, but it is not something I have experienced before.
on the seventh day, my arm got red and swollen and severe fatigue overcame me.  I spent two days in bed, missing work.  I have been unable to exercise since that day.  I have used antihistamines and steroid ointment to control the redness, swelling and itching on my arm for one week.  when I miss a dose it returns.
No adverse reaction occurred. Patient received a Moderna vaccine that expired 03/27/22. Manufacture was contacted the response was: The vaccine administered  lot number 059H21A maintained the activity necessary to  protect against the SARS-CoV-2 (COVID-19) virus at time of administration.